FIELD: medicine.
SUBSTANCE: invention relates to pharmacology and medicine, particularly: the set applied to treatment for thrombosis, which includes compound with formula 
and aspirin; pharmaceutical composition, which includes compound with formula (1) and aspirin; and application of pharmaceutical composition, which includes compound with formula (1), and pharmaceutical composition, which includes aspirin to treatment for thrombosis.
EFFECT: providing of increased thrombosis therapy efficacy.
6 cl, 1 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMBINATIONS | 2000 |
|
RU2242232C2 |
| NEW COMBINATIONS OF KLOPIDOGREL-CONTAINING ACTIVE AGENT AND ANTITHROMBOSIS AGENT | 1997 |
|
RU2184547C2 |
| ANTITHROMBOTIC DUAL INHIBITORS CONTAINING BIOTIN LABEL | 2006 |
|
RU2434876C2 |
| VON WILLEBRAND FACTOR OR FACTOR VIII AND VON WILLEBRAND FACTOR FOR TREATMENT OF COAGULOPATHY, INDUCED BY PLATELET INHIBITORS | 2009 |
|
RU2563236C2 |
| PHARMACEUTICAL PREPARATION CONTAINING LOW-MOLECULAR THROMBIN INHIBITOR AND ITS PRE-MEDICINE | 2000 |
|
RU2252783C2 |
| USE OF ICARITIN FOR OBTAINING MEDICINAL PRODUCTS | 2021 |
|
RU2806093C1 |
| METHODS OF TREATING OR PREVENTING THROMBOSIS OR EMBOLISM | 2011 |
|
RU2611662C2 |
| OXAZOLIDINONES FOR TREATING AND/OR PREVENTING CARDIAC EMBARRASSMENTS | 2008 |
|
RU2494740C2 |
| LACTAM-CONTAINING COMPOUND AND ITS DERIVATIVES AS Xa FACTOR INHIBITORS | 2002 |
|
RU2345993C2 |
| USE OF 2-PHENYL-3-ARAYLBENZOTHIOPHENES FOR THROMBOMODULINE EXPRESSION ENHANCEMENT | 1994 |
|
RU2125450C1 |
